Tradestie Institutional Equity Comparison Engine

BIOA vs TLPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLPH Overall Edge

TLPH Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Talphera, Inc. Common Stock (TLPH) driven by superior Valuation, Momentum & Technical while BIOA counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, BIOA trades at N/M Forward P/E with -1401.8% operating margin (-85.5% YoY revenue) versus TLPH at 1.0x Forward P/E and -1474700.0% operating margin (+0.0% YoY). In options structure, BIOA sits in BREAKDOWN (24th %ile IV; Dealer Gamma Walls on Pro) against TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLPH
BIOA N/M vs TLPH 1.0x Fwd P/E
Growth & Margin Winner BIOA
Op Margin -1401.8% vs -1474700.0% ยท YoY -85.5% vs +0.0%
Momentum & Technical Winner TLPH
1Y -33.0% vs -18.0% ยท 52W Pos 2% vs 20%
Options & Structure Winner BIOA
BREAKDOWN (24th %ile IV) vs UNCLASSIFIED (100th %ile IV)
BIOA NASDAQ
BioAge Labs, Inc. Common Stock
Pharmaceutical Preparations
$5.17
-6.85% 1D
Market Cap $259.6M
1M Return +6.82%
1Y Return -33.03%
Forward P/E N/M
Unified AI Score
36.0 / 100 SELL
Tech 20.0 Fund 49.0 Flow 63.0 Mom 60.0
TLPH NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap $53.7M
1M Return -20.29%
1Y Return -18.01%
Forward P/E 1.0x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BIOA -33.03% TLPH -18.01% Spread: +15.02 pp (TLPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BIOA TTM Op. Margin: -1401.8% TLPH TTM Op. Margin: -1474700.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIOA vs TLPH. Trailing 12-month operating profitability (BIOA -1401.8% vs TLPH -1474700.0%) and valuation multiples (BIOA N/M vs TLPH 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BIOA (3) vs TLPH (6)
Institutional Metric BIOA TLPH Criterion Row Winner
Market Capitalization Scale $259.6M $53.7M Larger Scale BIOA
Trailing P/E Ratio Valuation N/M 1.0x Lower Multiple TLPH
Forward P/E Ratio Valuation N/M 1.0x Lower Multiple TLPH
Revenue Growth (YoY) Growth -85.5% +0.0% Higher Growth TLPH
Operating Margin (TTM) Profitability -1401.8% -1474700.0% Higher Margin BIOA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -34.6% -143.4% Higher ROE BIOA
52-Week Range Position Momentum 2% ($5โ€“$26) 20% ($1โ€“$2) Stronger Trend TLPH
Beta / 30D Volatility Risk Regime 2.21ฮฒ ยท 83% Vol 1.11ฮฒ ยท 58% Vol Lower Realized Risk TLPH
Unified Institutional Score Composite Signal 36.0 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite TLPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BIOA vs TLPH Buy Guide
BIOA BREAKDOWN
95d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 24th %ile
IV Regime Compressed (<25th %ile)
Live BIOA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TLPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BIOA nor TLPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.